Logo Logo Logo Logo Logo
  • Home
  • About
    • About Atomo
    • Board of Directors
    • Executive Team
    • Governance
  • OEM Devices
    • Device Platforms
      • Elion RDT platform
      • Pascal RDT platform
      • Galileo RDT platform
      • Losev RDT platform
      • Newton RDT platform
      • Franklin RDT platform
    • OEM Service
      • Development Pathway
  • COVID-19
  • HIV
    • HIV Professional Use Test
    • HIV Self Testing
  • News
    • Press Releases
    • News
  • Investor Centre
  • Contact
    • Media Centre
  • Home
  • About
    • About Atomo
    • Board of Directors
    • Executive Team
    • Governance
  • OEM Devices
    • Device Platforms
      • Elion RDT platform
      • Pascal RDT platform
      • Galileo RDT platform
      • Losev RDT platform
      • Newton RDT platform
      • Franklin RDT platform
    • OEM Service
      • Development Pathway
  • COVID-19
  • HIV
    • HIV Professional Use Test
    • HIV Self Testing
  • News
    • Press Releases
    • News
  • Investor Centre
  • Contact
    • Media Centre

11 Nov Ausbiz: The Strawman Classic Week 3 – The double CEO special (AT1, TNT)

Posted at 08:22h in News by Kavish Buddoo 0 Comments
0 Likes

Our MD John Kelly sat down with Ausbiz to talk about Atomo’s strong growth, our solid progress with commercialising our rapid diagnostics tests and securing licensing deals with partners.   Watch the interview here    ...

Read More

04 Nov TGA approves Atomo’s rapid antigen COVID-19 test

Posted at 15:19h in News by Kavish Buddoo 0 Comments
0 Likes

Atomo was featured in a recent article by Biotech Dispatch regarding the TGA approval of Atomo’s rapid antigen COVID-19 test.   Read Article Here    ...

Read More

04 Nov WA and Queensland Borders Start to Come Down

Posted at 10:01h in News by Kavish Buddoo 0 Comments
0 Likes

As WA and QLD take first steps to reopen borders, our CEO, John Kelly was asked to comment in the Australian Financial Review on how an antigen / antibody testing combo could help Australia to open up with more confidence.   Read Article Here    ...

Read More

29 Oct Atomo’s 15 minute COVID test gets its second key nod

Posted at 11:23h in News by Kavish Buddoo 0 Comments
0 Likes

Our MD, John Kelly was interviewed by Ausbiz about TGA approval for our COVID-19 rapid antigen test.   Watch the Interview Here    ...

Read More

29 Oct Why the Atomo (ASX:AT1) share price is flying 9% higher today

Posted at 11:14h in News by Kavish Buddoo 0 Comments
0 Likes

Motley Fool talks about our share price gain following TGA approval of our COVID-19 rapid antigen test.   Read the full article >    ...

Read More

29 Oct Atomo Diagnostics (ASX:AT1) gets TGA approval for 15-minute COVID-19 test

Posted at 11:10h in News by Kavish Buddoo 0 Comments
0 Likes

The Market Herald discusses the TGA approval for our COVID-19 rapid antigen test.   Read the full article >    ...

Read More

29 Oct Atomo’s COVID-19 nasal swab test gets green light from TGA

Posted at 11:03h in News by Kavish Buddoo 0 Comments
0 Likes

This Business News Australia discusses the benefits of our COVID-19 and the convenience of the 15-minute test.   Read the full article >    ...

Read More

02 Oct Atomo gains rights to rapid COVID-19 diagnostic

Posted at 12:56h in News by Kavish Buddoo 0 Comments
0 Likes

An article by Biotech Dispatch on our expanded partnership with Access Bio to launch a rapid COVID-19 antigen test in Australia, New Zealand and India.   Read the full article >    ...

Read More

02 Oct “Game changing” deal for Aussie biotech Atomo

Posted at 12:49h in News by Kavish Buddoo 0 Comments
0 Likes

Our MD, John Kelly sat down with Ausbiz to discuss our rapid antigen test deal with Access Bio which will enable screening for COVID-19 acute infection and exposure at the same time.   Watch the Video    ...

Read More

30 Sep DIVOC Labs to sell Atomo’s COVID-19 rapid antibody test in India

Posted at 13:52h in News by Kavish Buddoo 0 Comments
0 Likes

An article by Biotech Dispatch on our agreement with DIVOC labs to launch our rapid COVID-19 antibody test in India.   Read the full article >    ...

Read More

30 Sep Why the Atomo (ASX:AT1) share price is moving higher today

Posted at 13:51h in News by Kavish Buddoo 0 Comments
0 Likes

An article by Motley Fool on our expanded a partnership with Access Bio to launch a rapid COVID-19 antigen test in Australia, New Zealand and India.   Read the full article >    ...

Read More

30 Sep Atomo (ASX:AT1) share price rockets 10% on new agreement

Posted at 13:51h in News by Kavish Buddoo 0 Comments
0 Likes

An article by Motley Fool on our agreement with DIVOC labs to launch our rapid COVID-19 antibody test in India.   Read the full article >    ...

Read More

09 Sep COVID has opened up potentially lucrative opportunities for these Aussie microcaps

Posted at 20:43h in News by Rebecca James 0 Comments
0 Likes

Atomo is mentioned in this Stockhead article as one of the Aussie companies involved in the efforts against COVID-19.   Read the full article >    ...

Read More

01 Sep Aussie biotechs join crusade for COVID-19 cure

Posted at 10:37h in News, Uncategorized by Rebecca James 0 Comments
0 Likes

An article by Stockhead talks about our FY20 results and our COVID-19 antibody tests.   Read the full article >    ...

Read More

31 Aug Atomo Diagnostics’ (ASX:AT1) revenue soars 900pc amid COVID-19 demand

Posted at 19:28h in News by Rebecca James 0 Comments
0 Likes

Medical diagnostics company Atomo Diagnostics (AT1) has seen its revenue jump nearly 900 per cent over FY20 as demand for COVID-19 antibody tests skyrockets.   Read the full article >    ...

Read More

31 Aug The world’s best test

Posted at 10:43h in News by Rebecca James 0 Comments
0 Likes

An interview with Atomo MD, John Kelly on our FY20 results and strong uplift in revenues.   Watch the full interview >  ...

Read More

11 Aug Biotech Dispatch: TGA approval for Atomo Diagnostics’ COVID-19 diagnostic

Posted at 21:08h in News by Rebecca James 0 Comments
0 Likes

Atomo Diagnostics (ASX: AT1) has announced that the TGA has approved its rapid SARS-CoV-2 antibody blood test for use by medical professionals in Australia.   Read the full article >    ...

Read More

10 Aug AFR: Atomo surges 16pc after COVID test gets TGA approval

Posted at 22:10h in News by Rebecca James 0 Comments
0 Likes

The healthcare community and broader market initially misunderstood the role of Atomo Diagnostic's COVID-19 antibody test, with CEO John Kelly saying it is designed to be used in conjunction with the gold-standard molecular polymerase chain reaction (PCR) swabs, not as a replacement.   Read the full article >...

Read More

10 Aug Ausbiz: The Aussie COVID test that takes 15 minutes

Posted at 22:09h in News by Rebecca James 0 Comments
0 Likes

MD and CEO discusses TGA approval for our COVID-19 antibody test in this video interview.   Read the full article >    ...

Read More

10 Aug BioWorld: TGA approves Atomo Diagnostics’ rapid COVID-19 antibody test

Posted at 21:18h in News by Rebecca James 0 Comments
0 Likes

As the state of Victoria in Australia records its deadliest day since the COVID-19 pandemic began, reporting 17 deaths and 394 new cases, Atomo Diagnostics Ltd.’s new COVID-19 antibody test could ease pressure on health care systems.   Read the full article >...

Read More

05 Aug CNBC: Covid testing to support future rollout of vaccine: Atomo Diagnostics

Posted at 19:22h in News by Rebecca James 0 Comments
0 Likes

In this interview, CEO John Kelly talks about how COVID-19 antibody testing will be important to verify any future vaccine for the virus.   Watch the interview >    ...

Read More

03 Aug BioSpectrum Asia: Atomo Diagnostics collaborates with Access Bio for rapid COVID-19 testing

Posted at 18:26h in News by Rebecca James 0 Comments
0 Likes

An article in BioSpectrum Asia on Atomo’s agreement with US-based Access Bio Inc. for COVID-19 antibody testing in North America.   Read the full article >    ...

Read More

30 Jul Stockhead: COVID-19 testing will last for ‘several years not several months’

Posted at 18:11h in News by Rebecca James 0 Comments
0 Likes

In this Stockhead article, CEO, John Kelly discusses why COVID-19 testing will continue for years not months, the development of a vaccine and how Atomo is focused on growing its non-COVID related businesses.   Read the full article >  ...

Read More

28 Jul BioSpace: Atomo Diagnostics and Access Bio partner to expand access to COVID-19 blood-based rapid testing in North America

Posted at 18:21h in News by Rebecca James 0 Comments
0 Likes

An article in BioSpace on Atomo’s agreement with US-based Access Bio Inc. for COVID-19 antibody testing in North America.   Read the full article >    ...

Read More

28 Jul Small Caps: Atomo Diagnostics partners with US biotech for global marketing of COVID-19 rapid test kits

Posted at 18:05h in News by Rebecca James 0 Comments
0 Likes

This article in Small Caps article talks about the agreement with US-based Access Bio Inc. for COVID-19 antibody testing in North America.   Read the full article >    ...

Read More

13 Jul The Scientist: How the Pharma Industry Pulled Off the Pivot to COVID-19

Posted at 18:00h in News by Rebecca James 0 Comments
0 Likes

Atomo CEO, John Kelly talks about why Atomo developed a rapid diagnostic test for COVID-19.   Read the full article >        ...

Read More

23 Jun ASX: Get to know ASX’s new public company: Atomo Diagnostics Limited (ASX: AT1)

Posted at 18:48h in News by Rebecca James 0 Comments
0 Likes

Managing Director and CEO, John Kelly talks to the ASX about the inspiration behind Atomo, listing on the ASX during COVID-19 and why having the right advisors is crucial when you IPO.   Watch the video and read the full interview here >    ...

Read More

05 Jun Ausbiz: Atomo’s new deal means regional production is ramping up just as the recession hits

Posted at 17:03h in News by Rebecca James 0 Comments
0 Likes

Managing Director and CEO, John Kelly talks to Ausbiz about Atomo’s expanded partnership with NG Biotech and securing exclusive rights to market and distribute the COVID-19 antibody test for Australia, NZ and parts of SE Asia.   Watch the interview here >      ...

Read More

04 Jun ASX Announcement: Atomo and NG Biotech expand COVID-19 partnership:

Posted at 09:02h in Press Release by Rebecca James 0 Comments
0 Likes

Atomo secures exclusive rights for Australia, New Zealand and South East Asia¹   SYDNEY Australia, Thursday, 4 June 2020 – Atomo Diagnostics Limited (ASX: AT1) (Atomo) is pleased to announce it has expanded its existing COVID-19 rapid test partnership with NG Biotech, SAS (NG Biotech), which was...

Read More

10 May Stockhead – Dr Boreham’s Crucible: A simpler device gives Atomo the upper hand in blood-based diagnostics

Posted at 18:28h in News by Rebecca James 0 Comments
0 Likes

Stockhead’s Tim Boreham discusses Atomo’s background and history and the benefits of its rapid blood test devices for a range of conditions including COVID-19.   Read the full article >  ...

Read More
  • 1
  • 2
Copyright 2020 Atomo Diagnostics
Privacy Policy
Australia (Head Office) Level 2, 701-703 Parramatta Road, Leichhardt, NSW 2040 Telephone: +61 (0)2 9099 4750